HIV-1 and HIV-2 Exhibit Divergent Interactions with HLTF and UNG2

Total Page:16

File Type:pdf, Size:1020Kb

HIV-1 and HIV-2 Exhibit Divergent Interactions with HLTF and UNG2 HIV-1 and HIV-2 exhibit divergent interactions with PNAS PLUS HLTF and UNG2 DNA repair proteins Kasia Hreckaa,1, Caili Haoa,1, Ming-Chieh Shuna, Sarabpreet Kaura, Selene K. Swansonb, Laurence Florensb, Michael P. Washburnb,c, and Jacek Skowronskia,2 aDepartment of Molecular Biology and Microbiology, Case Western Reserve School of Medicine, Cleveland, OH 44106; bStowers Institute for Medical Research, Kansas City, MO 64110; and cDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160 Edited by Stephen P. Goff, Columbia University College of Physicians and Surgeons, New York, NY, and approved May 20, 2016 (received for review March 29, 2016) HIV replication in nondividing host cells occurs in the presence antiviral proteins for degradation by the proteasome (13). In of high concentrations of noncanonical dUTP, apolipoprotein B particular, Vif loads antiviral APOBEC3 family proteins onto a mRNA-editing, enzyme-catalytic, polypeptide-like 3 (APOBEC3) CRL5 E3 ubiquitin ligase for polyubiquitination and subsequent cytidine deaminases, and SAMHD1 (a cell cycle-regulated dNTP proteasome-dependent degradation (14). Vpx, encoded by the triphosphohydrolase) dNTPase, which maintains low concentra- HIV-2/simian immunodeficiency virus (SIV) SIVsm lineage of tions of canonical dNTPs in these cells. These conditions favor primate lentiviruses, and closely related Vpr proteins from a the introduction of marks of DNA damage into viral cDNA, and subset of SIV viruses isolated from various primate species, thereby prime it for processing by DNA repair enzymes. Accessory counteract SAMHD1-mediated restriction (6, 7, 11). Specifically, protein Vpr, found in all primate lentiviruses, and its HIV-2/simian Vpx binds to the DCAF1 substrate receptor subunit of the immunodeficiency virus (SIV) SIVsm paralogue Vpx, hijack the CRL4DCAF1 E3 ubiquitin ligase and loads SAMHD1 onto this CRL4DCAF1 E3 ubiquitin ligase to alleviate some of these conditions, enzyme, thereby targeting it for degradation (15). Although HIV-1 but the extent of their interactions with DNA repair proteins has does not counteract SAMHD1 directly, it was proposed to bypass not been thoroughly characterized. Here, we identify HLTF, a post- the SAMHD1-imposed restriction as a result of a more efficient replication DNA repair helicase, as a common target of HIV-1/ reverse transcriptase that can synthesize viral cDNA in a low-dNTP SIVcpz Vpr proteins. We show that HIV-1 Vpr reprograms environment (16). The failure of the aforementioned viral coun- DCAF1 CRL4 E3 to direct HLTF for proteasome-dependent degrada- termeasures flags HIV cDNA for processing by DNA repair tion independent from previously reported Vpr interactions with enzymes, which, if not successfully completed in a low-dNTP base excision repair enzyme uracil DNA glycosylase (UNG2) and environment set up by SAMHD1, could lead to the initiation of crossover junction endonuclease MUS81, which Vpr also directs an innate response to viral nucleic acids, increased HIV-1 mu- for degradation via CRL4DCAF1 E3. Thus, separate functions of – DCAF1 tation rate, and/or inhibition of HIV-1 infection (17 19). HIV-1 Vpr usurp CRL4 E3 to remove key enzymes in three Vpr, a paralogue of Vpx found in all primate lentiviruses, coor- DNA repair pathways. In contrast, we find that HIV-2 Vpr is unable dinates interactions with postreplication DNA repair machinery, to efficiently program HLTF or UNG2 for degradation. Our find- whose role for the replication cycle of primate lentiviruses is not MICROBIOLOGY ings reveal complex interactions between HIV-1 and the DNA re- well understood. Early studies revealed that HIV-1 Vpr modulates pair machinery, suggesting that DNA repair plays important roles mutation rates in plasmid shuttle vectors in model systems (20, in the HIV-1 life cycle. The divergent interactions of HIV-1 and HIV-2 with DNA repair enzymes and SAMHD1 imply that these Significance viruses use different strategies to guard their genomes and facil- itate their replication in the host. In nondividing host cells, HIV is targeted by intrinsic antiviral HIV | Vpr | postreplication DNA repair | SAMHD1 | restriction defense mechanisms that introduce marks of damage into viral cDNA, thereby tagging it for processing by cellular DNA repair machinery. Surprisingly, our findings reveal that the two main ondividing memory T cells and myeloid cells are the main types of HIV exhibit very different interactions with enzymes Ntargets of primate lentiviruses during the initial weeks of the – involved in DNA repair. HIV-1, but not HIV-2, efficiently removes acute, in vivo infection (1 4). Infection of these cells is inhibited select DNA repair enzymes, whereas HIV-2 increases dNTP supply by intrinsic and innate antiviral mechanisms, several of which con- in infected cells by removing SAMHD1 (a cell cycle-regulated dNTP verge on reverse transcription of the viral RNA genome. One such triphosphohydrolase) dNTPase. Our findings imply that increasing restriction is imposed by SAMHD1, a cell cycle-regulated dNTP dNTP supply during viral cDNA synthesis or repair, or blocking triphosphohydrolase that, in G1-phase leukocytes, maintains the cDNA processing by DNA repair enzymes, are alternative strate- concentrations of canonical dNTPs below the threshold required for gies used by HIV-2 and HIV-1 to guard their DNA genomes and efficient reverse transcription (5–8). Another is caused by a rela- facilitate their replication/persistence in the host. tively high concentration of noncanonical deoxyuridine triphosphate compared with canonical TTP. dUTP is a substrate for HIV reverse Author contributions: K.H., C.H., M.-C.S., S.K., S.K.S., L.F., M.P.W., and J.S. designed re- transcriptase, which leads to uracil incorporation into viral cDNA. search; K.H., C.H., M.-C.S., S.K., and S.K.S. performed research; L.F. and M.P.W. contrib- uted new reagents/analytic tools; K.H., C.H., M.-C.S., S.K., S.K.S., L.F., M.P.W., and J.S. HIV reverse transcripts are heavily uracilated in macrophages analyzed data; and J.S. wrote the paper. (9, 10). Moreover, viral cDNA is a substrate for apolipoprotein B The author declares no conflict of interest. mRNA-editing, enzyme-catalytic, polypeptide-like 3 (APOBEC3)- This article is a PNAS Direct Submission. family editing enzymes, which convert cytidine to uridine in the Data deposition: The complete MudPIT mass spectrometry dataset (raw files, peak files, minus strand of HIV reverse-transcription intermediates (6, 7, 11, search files, as well as DTASelect result files) can be obtained from the MassIVE database 12). The latter two mechanisms flag viral cDNA for processing by via ftp://[email protected] with password KHJS60144. cellular DNA repair enzymes. 1K.H. and C.H. contributed equally to this work. The restriction mechanisms that target lentivirus genome rep- 2To whom correspondence should be addressed. Email: [email protected]. lication are counteracted by accessory virulence proteins Vif, Vpx, This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. and Vpr, which usurp specific cellular E3 ubiquitin ligases to direct 1073/pnas.1605023113/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1605023113 PNAS | Published online June 22, 2016 | E3921–E3930 21). Vpr, like Vpx, binds the DCAF1 subunit of the CRL4DCAF1 (41, 42). The presence of multiple proteins involved with DNA E3 complex and hijacks this enzyme (22). This interaction is repair was not surprising, as HIV-1 Vpr and DCAF1 were reported associated with the induction of DNA repair foci and activation to colocalize with DNA repair foci in chromatin (23). The presence of the serine/threonine kinase ATR-controlled DNA damage of UNG2, a known, specific substrate of the CRL4DCAF1-H1.Vpr checkpoint; the latter usually reflects the presence of, or failure E3, in MudPIT datasets indicates that our experimental approach to repair, damaged DNA at replication forks (23–25). Al- detects cellular proteins that Vpr recruits to the CRL4DCAF1 E3 though the exact mechanism by which Vpr mediates the in- ubiquitin ligase and thereby directs for proteasome-dependent duction of replication stress is unclear, it was recently linked degradation. to the Vpr-mediated recruitment of SLX4-SLX1/MUS81-EME1 structure-specific endonucleases to DCAF1, resulting in activation HIV-1 Vpr Down-Regulates HLTF, a Postreplication DNA Repair Helicase. of the MUS81-EME1 endonuclease and, surprisingly, DCAF1- To assess whether any of the 21 identified DNA repair proteins is a and proteasome-dependent MUS81 degradation (26). Sepa- potential substrate of CRL4DCAF1-H1.Vpr E3, we first tested their rately, HIV-1 and HIV-2 Vpr were reported to bind a base levels in CEM.SS-iH1.Vpr and/or U2OS-iH1.Vpr, the latter also excision repair enzyme, uracil DNA glycosylase (UNG2), harboring a doxycycline-inducible HIV-1 NL4-3 Vpr transgene (Fig. which can restrict HIV-1 infection in cells with high concen- S1). Of note, U2OS cells retain many of the cell cycle regulation trations of dUTP (19, 27–29). HIV-1 Vpr was shown to tar- characteristics of normal cells and are commonly used for cell cycle/ get UNG2 to the ubiquitin proteasome pathway via the DNA repair/replication studies. Interestingly, the levels of endoge- CRL4DCAF1 E3 complex and thereby disrupt UNG2-initiated base nous HLTF were much lower in CEM.SS-iH1.Vpr and U2OS-iH1. excision repair in HIV-1–infected cells (30–32). Vpr cells that had been arrested by Vpr at the DNA damage The fact that cellular restriction factors flag HIV cDNA for checkpoint in the G2 phase of the cell cycle compared with control processing by DNA repair enzymes, taken together with the asynchronously dividing cells that did not express Vpr (Fig. S1). considerable complexity of cellular repair machineries, raises the Significantly, HLTF was not depleted in control cells arrested possibility that Vpr coordinately engages DNA repair pathways.
Recommended publications
  • Escape from X Chromosome Inactivation Is an Intrinsic Property of the Jarid1c Locus
    Escape from X chromosome inactivation is an intrinsic property of the Jarid1c locus Nan Lia,b and Laura Carrela,1 aDepartment of Biochemistry and Molecular Biology and bIntercollege Graduate Program in Genetics, Pennsylvania State College of Medicine, Hershey, PA 17033 Edited by Stanley M. Gartler, University of Washington, Seattle, WA, and approved September 23, 2008 (received for review August 8, 2008) Although most genes on one X chromosome in mammalian fe- Sequences on the X are hypothesized to propagate XCI (12) and males are silenced by X inactivation, some ‘‘escape’’ X inactivation to be depleted at escape genes (8, 9). LINE-1 repeats fit such and are expressed from both active and inactive Xs. How these predictions, particularly on the human X (8–10). Distinct dis- escape genes are transcribed from a largely inactivated chromo- tributions of other repeats classify some mouse X genes (5). some is not fully understood, but underlying genomic sequences X-linked transgenes also test the role of genomic sequences in are likely involved. We developed a transgene approach to ask escape gene expression. Most transgenes are X-inactivated, whether an escape locus is autonomous or is instead influenced by although a number escape XCI (e.g., refs. 13 and 14). Such X chromosome location. Two BACs carrying the mouse Jarid1c gene transgene studies indicate that, in addition to CTCF (6), locus and adjacent X-inactivated transcripts were randomly integrated control regions and matrix attachment sites are also not suffi- into mouse XX embryonic stem cells. Four lines with single-copy, cient to escape XCI (15, 16).
    [Show full text]
  • DDB1 Targets Chk1 to the Cul4 E3 Ligase Complex in Normal Cycling Cells and in Cells Experiencing Replication Stress
    Published OnlineFirst March 10, 2009; DOI: 10.1158/0008-5472.CAN-08-3382 Research Article DDB1 Targets Chk1 to the Cul4 E3 Ligase Complex in Normal Cycling Cells and in Cells Experiencing Replication Stress Van Leung-Pineda,1 Jiwon Huh,1 and Helen Piwnica-Worms1,2,3 Departments of 1Cell Biology and Physiology and 2Internal Medicine and 3Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri Abstract protein FANCE (8, 10–12). Chk1 carries out its functions both in the The Chk1 protein kinase preserves genome integrity in normal nucleus and at the centrosome (13). Drugs that block Chk1 kinase proliferating cells and in cells experiencing replicative and activity or enhance its proteolysis by interfering with binding to genotoxic stress. Chk1 is currently being targeted in antican- heat shock protein 90 (HSP90) are currently being tested as cer regimens. Here, we identify damaged DNA-binding protein anticancer agents (14–17). 1 (DDB1) as a novel Chk1-interacting protein. DDB1 is part of Chk1 is regulated by reversible phosphorylation and by an E3 ligase complex that includes the cullin proteins Cul4A ubiquitin-mediated proteolysis. Under periods of replicative stress, and Cul4B. We report that Cul4A/DDB1 negatively regulates the ATRIP/ATR module binds to single-stranded DNA and, Chk1 stability in vivo. Chk1 associates with Cul4A/DDB1 together with Rad17 and the 9-1-1 complex, activates Chk1 in a Claspin-dependent manner (18–22). ATR directly phosphorylates during an unperturbed cell division cycle and both Chk1 317 345 phosphorylation and replication stress enhanced these inter- Chk1 on two COOH-terminal residues: Ser (S317) and Ser actions.
    [Show full text]
  • The Role and Mechanism of CRL4 E3 Ubiquitin Ligase in Cancer and Its Potential Therapy Implications
    www.impactjournals.com/oncotarget/ Oncotarget, Vol. 6, No. 40 The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications Youzhou Sang1,3,4, Fan Yan1,3,4 and Xiubao Ren2,3,4 1 Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China 2 Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China 3 National Clinical Research Center of Cancer, Tianjin, China 4 Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China Correspondence to: Xiubao Ren, email: [email protected] Keywords: CRL4, CUL4, ubiquitination, cancer Received: April 08, 2015 Accepted: September 23, 2015 Published: October 09, 2015 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT CRLs (Cullin-RING E3 ubiquitin ligases) are the largest E3 ligase family in eukaryotes, which ubiquitinate a wide range of substrates involved in cell cycle regulation, signal transduction, transcriptional regulation, DNA damage response, genomic integrity, tumor suppression and embryonic development. CRL4 E3 ubiquitin ligase, as one member of CRLs family, consists of a RING finger domain protein, cullin4 (CUL4) scaffold protein and DDB1–CUL4 associated substrate receptors. The CUL4 subfamily includes two members, CUL4A and CUL4B, which share extensively sequence identity and functional redundancy. Aberrant expression of CUL4 has been found in a majority of tumors. Given the significance of CUL4 in cancer, understanding its detailed aspects of pathogenesis of human malignancy would have significant value for the treatment of cancer.
    [Show full text]
  • Hyperphosphorylation Repurposes the CRL4B E3 Ligase to Coordinate Mitotic Entry and Exit
    Research Collection Doctoral Thesis Identification and Characterization of Novel Cullin 4-based E3 Ligases in Somatic Cell Division Author(s): da Graça Gilberto, Samuel Filipe Publication Date: 2017 Permanent Link: https://doi.org/10.3929/ethz-b-000219014 Rights / License: In Copyright - Non-Commercial Use Permitted This page was generated automatically upon download from the ETH Zurich Research Collection. For more information please consult the Terms of use. ETH Library DISS. ETH NO. 24583 Identification and characterization of novel Cullin 4-based E3 ligases in somatic cell division A thesis submitted to attain the degree of DOCTOR OF SCIENCES of ETH ZURICH (Dr. sc. ETH Zurich) Presented by SAMUEL FILIPE DA GRAÇA GILBERTO MSc in Biochemistry, University of Lisbon Born on 21.02.1988 Citizen of Portugal Accepted on the recommendation of Prof. Dr. Matthias Peter Prof. Dr. Anton Wutz 2017 Table of contents 1. General introduction ..................................................................................................................1 1.1. The ubiquitylation machinery ....................................................................................................... 1 1.2. Principles of cell cycle regulation: a focus on CRLs and the APC/C .............................................. 3 1.3. Cullin-4 RING E3 ligases: cell-cycle regulation and beyond ........................................................ 14 1.4. Functional distinctions between CUL4A and CUL4B ..................................................................
    [Show full text]
  • And CAND1-Dependent Remodelling of the Budding Yeast SCF Complex
    ARTICLE Received 31 Jan 2013 | Accepted 20 Feb 2013 | Published 27 Mar 2013 DOI: 10.1038/ncomms2628 OPEN CSN- and CAND1-dependent remodelling of the budding yeast SCF complex Aleksandra Zemla1, Yann Thomas1, Sylwia Kedziora1, Axel Knebel1, Nicola T Wood1, Gwenae¨l Rabut2 & Thimo Kurz1 Cullin–RING ligases (CRLs) are ubiquitin E3 enzymes with variable substrate-adaptor and -receptor subunits. All CRLs are activated by modification of the cullin subunit with the ubiquitin-like protein Nedd8 (neddylation). The protein CAND1 (Cullin-associated-Nedd8- dissociated-1) also promotes CRL activity, even though it only interacts with inactive ligase complexes. The molecular mechanism underlying this behaviour remains largely unclear. Here, we find that yeast SCF (Skp1–Cdc53–F-box) Cullin–RING complexes are remodelled in a CAND1-dependent manner, when cells are switched from growth in fermentable to non-fermentable carbon sources. Mechanistically, CAND1 promotes substrate adaptor release following SCF deneddylation by the COP9 signalosome (CSN). CSN- or CAND1- mutant cells fail to release substrate adaptors. This delays the formation of new complexes during SCF reactivation and results in substrate degradation defects. Our results shed light on how CAND1 regulates CRL activity and demonstrate that the cullin neddylation– deneddylation cycle is not only required to activate CRLs, but also to regulate substrate specificity through dynamic substrate adaptor exchange. 1 Scottish Institute for Cell Signalling, Protein Ubiquitylation Unit, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, Scotland, UK. 2 CNRS, Universite´ Rennes 1, Institut de Ge´ne´tique et De´veloppement de Rennes, 2 avenue du Professeur Le´on Bernard, CS 34317, Rennes Cedex 35043, France.
    [Show full text]
  • Fine-Scale Survey of X Chromosome Copy Number Variants and Indels Underlying Intellectual Disability
    ARTICLE Fine-Scale Survey of X Chromosome Copy Number Variants and Indels Underlying Intellectual Disability Annabel C. Whibley,1 Vincent Plagnol,1,2 Patrick S. Tarpey,3 Fatima Abidi,4 Tod Fullston,5,6 Maja K. Choma,1 Catherine A. Boucher,1 Lorraine Shepherd,1 Lionel Willatt,7 Georgina Parkin,7 Raffaella Smith,3 P. Andrew Futreal,3 Marie Shaw,8 Jackie Boyle,9 Andrea Licata,4 Cindy Skinner,4 Roger E. Stevenson,4 Gillian Turner,9 Michael Field,9 Anna Hackett,9 Charles E. Schwartz,4 Jozef Gecz,5,6,8 Michael R. Stratton,3 and F. Lucy Raymond1,* Copy number variants and indels in 251 families with evidence of X-linked intellectual disability (XLID) were investigated by array comparative genomic hybridization on a high-density oligonucleotide X chromosome array platform. We identified pathogenic copy number variants in 10% of families, with mutations ranging from 2 kb to 11 Mb in size. The challenge of assessing causality was facilitated by prior knowledge of XLID-associated genes and the ability to test for cosegregation of variants with disease through extended pedigrees. Fine-scale analysis of rare variants in XLID families leads us to propose four additional genes, PTCHD1, WDR13, FAAH2, and GSPT2,as candidates for XLID causation and the identification of further deletions and duplications affecting X chromosome genes but without apparent disease consequences. Breakpoints of pathogenic variants were characterized to provide insight into the underlying mutational mechanisms and indicated a predominance of mitotic rather than meiotic events. By effectively bridging the gap between karyotype-level investigations and X chromosome exon resequencing, this study informs discussion of alternative mutational mechanisms, such as non- coding variants and non-X-linked disease, which might explain the shortfall of mutation yield in the well-characterized International Genetics of Learning Disability (IGOLD) cohort, where currently disease remains unexplained in two-thirds of families.
    [Show full text]
  • CUL4B Promotes Proliferation and Inhibits Apoptosis of Human Osteosarcoma Cells
    ONCOLOGY REPORTS 32: 2047-2053, 2014 CUL4B promotes proliferation and inhibits apoptosis of human osteosarcoma cells ZHI CHEN1*, BAO-LIANG SHEN2*, QING-GE FU3*, FEI WANG1, YI-XING TANG1, CANG-LONG HOU1 and LI CHEN1 1Department of Orthopedics, Changhai Hospital Affiliated to the Second Military Medical University, Shanghai 200433; 2Department of Orthopedics, Shanghai Jiading Central Hospital, Shanghai 201800; 3Department of Emergency and Trauma, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, P.R. China Received March 4, 2014; Accepted June 10, 2014 DOI: 10.3892/or.2014.3465 Abstract. Cullin 4B (CUL4B) is a component of the Introduction Cullin4B-Ring E3 ligase complex (CRL4B) that functions in proteolysis and is implicated in tumorigenesis. Here, we report Osteosarcoma is a primary bone malignancy with high rates that CUL4B is associated with tumorigenesis by promoting of metastasis, mortality and disability, and usually occurs in proliferation and inhibiting apoptosis of human osteosarcoma children and adolescents (1). The most common treatments cells. We performed RNA interference (RNAi) with a lentiviral for osteosarcoma are surgery, chemotherapy and biotherapy. vector system to silence the CUL4B gene using osteosarcoma However, the prognosis of osteosarcoma is still poor because SAOS-2 cells. The negative control included the normal of the high degree of malignancy, rapid disease progression target cells infected with the negative control virus whereas and early metastasis (2). the knockdown cells included the normal target cells trans- Gene amplification can be defined as increased copy fected with the RNAi target virus. We assessed the inhibition numbers of certain regions of the genome. Gene amplifica- resulting from the decreased expression of the CUL4B gene on tion often results in the upregulation of gene expression by the proliferation rate of SAOS-2 cells, and also evaluated the increasing the number of templates available for transcription.
    [Show full text]
  • Cul4a Promotes Zebrafish Primitive Erythropoiesis Via Upregulating Scl
    Yang et al. Cell Death and Disease (2019) 10:388 https://doi.org/10.1038/s41419-019-1629-7 Cell Death & Disease ARTICLE Open Access Cul4a promotes zebrafish primitive erythropoiesis via upregulating scl and gata1 expression Fan Yang1, Huili Hu1, Yuanyuan Liu2,MingShao2, Changshun Shao 3 and Yaoqin Gong1 Abstract CUL4A and CUL4B are closely related members in Cullin family and can each assemble a Cullin-RING E3 ligase complex (Cullin-RING Ligase 4A or 4B, CRL4A, or CRL4B) and participate in a variety of biological processes. Previously we showed that zebrafish cul4a, but not cul4b, is essential for cardiac and pectoral fin development. Here, we have identified cul4a as a crucial regulator of primitive erythropoiesis in zebrafish embryonic development. Depletion of cul4a resulted in a striking reduction of erythroid cells due to the inhibition of erythroid differentiation. Transcript levels for early hematopoietic regulatory genes including scl, lmo2, and gata1 are significantly reduced in cul4a-deficient embryos. Mechanistically, we demonstrated that scl and gata1, the central regulators of primitive hematopoiesis for erythroid determination, are transcriptionally upregulated by cul4a. These findings demonstrate an important role for cul4a in primitive erythropoiesis and may bear implications in regeneration medicine of anemia and related diseases. Introduction 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; which subsequently forms intermediate cell mass (ICM) Zebrafish (Danio rerio) has become a powerful model at the midline5,6. A sophisticated network of many tran- for investigating hematopoiesis because its transparency scription factors has been described to regulate primitive greatly facilitates the visualization of hematopoietic sys- and definitive hematopoiesis7. Among them, the stem cell tem.
    [Show full text]
  • The Emerging Role for Cullin 4 Family of E3 Ligases in Tumorigenesis T ⁎ ⁎ Ji Chenga,B,1, Jianping Guob,1, Brian J
    BBA - Reviews on Cancer 1871 (2019) 138–159 Contents lists available at ScienceDirect BBA - Reviews on Cancer journal homepage: www.elsevier.com/locate/bbacan Review The emerging role for Cullin 4 family of E3 ligases in tumorigenesis T ⁎ ⁎ Ji Chenga,b,1, Jianping Guob,1, Brian J. Northb, Kaixiong Taoa, Pengbo Zhouc, , Wenyi Weib, a Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China b Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA c Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, 1300 York Ave., New York, NY 10065, USA ARTICLE INFO ABSTRACT Keywords: As a member of the Cullin-RING ligase family, Cullin-RING ligase 4 (CRL4) has drawn much attention due to its CRL4, Cullin 4 broad regulatory roles under physiological and pathological conditions, especially in neoplastic events. Based on E3 ligases evidence from knockout and transgenic mouse models, human clinical data, and biochemical interactions, we PROTACs summarize the distinct roles of the CRL4 E3 ligase complexes in tumorigenesis, which appears to be tissue- and Tumorigenesis context-dependent. Notably, targeting CRL4 has recently emerged as a noval anti-cancer strategy, including Targeted therapy thalidomide and its derivatives that bind to the substrate recognition receptor cereblon (CRBN), and anticancer sulfonamides that target DCAF15 to suppress the neoplastic proliferation of multiple myeloma and colorectal cancers, respectively. To this end, PROTACs have been developed as a group of engineered bi-functional che- mical glues that induce the ubiquitination-mediated degradation of substrates via recruiting E3 ligases, such as CRL4 (CRBN) and CRL2 (pVHL).
    [Show full text]
  • Short Article CAND1 Binds to Unneddylated CUL1 and Regulates
    Molecular Cell, Vol. 10, 1519–1526, December, 2002, Copyright 2002 by Cell Press CAND1 Binds to Unneddylated CUL1 Short Article and Regulates the Formation of SCF Ubiquitin E3 Ligase Complex Jianyu Zheng,1 Xiaoming Yang,1 Despite the importance of cullins in controlling many Jennifer M. Harrell,1 Sophia Ryzhikov,1 essential biological processes, the mechanism that reg- Eun-Hee Shim,1 Karin Lykke-Andersen,2 ulates the cullin-containing ubiquitin E3 ligases remains Ning Wei,2 Hong Sun,1 Ryuji Kobayashi,3 unclear. In SCF, the F box proteins are short-lived pro- and Hui Zhang1,4 teins that undergo CUL1/SKP1-dependent degradation 1Department of Genetics (Wirbelauer et al., 2000; Zhou and Howley, 1998). Dele- Yale University School of Medicine tion of the F box region abolishes the binding of F box 333 Cedar Street proteins to SKP1 and CUL1, and consequently increases 2 Department of Molecular, Cellular, the stability of F box proteins. This substrate-indepen- and Developmental Biology dent proteolysis of F box proteins is likely the result of Yale University autoubiquitination by the ubiquitin E2 and E1 enzymes New Haven, Connecticut 06520 through a CUL1/SKP1-dependent mechanism. 3 Cold Spring Harbor Laboratory The carboxy-terminal ends of cullins are often covalently Cold Spring Harbor, New York 11724 modified by a ubiquitin-like protein, NEDD8/RUB1, and this modification appears to associate with active E3 li- gases (Hochstrasser, 2000). Like ubiquitin modification, Summary neddylation requires E1 (APP-BP1 and UBA3)-activating and E2 (UBC12)-conjugating enzymes (Hochstrasser, The SCF ubiquitin E3 ligase regulates ubiquitin-depen- 2000).
    [Show full text]
  • Regulation and Modulation of Human DNA Polymerase Δ Activity and Function
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 10 July 2017 doi:10.20944/preprints201707.0016.v1 Peer-reviewed version available at Genes 2017, 8, 190; doi:10.3390/genes8070190 Review Regulation and Modulation of Human DNA Polymerase δ Activity and Function Marietta Y.W.T. Lee1*, Xiaoxiao Wang, Sufang Zhang, Zhongtao Zhang and Ernest Y.C. Lee. 1 Dept. Biochemistry and Molecular Biology; [email protected] * Correspondence: [email protected]; Tel.: +01-914-594-4070 Abstract: This review focuses on the regulation and modulation of human DNA polymerase δ (Pol δ). The emphasis is on mechanisms that regulate the activity and properties of Pol δ in DNA repair and replication. The areas covered are the degradation of the p12 subunit of Pol δ, which converts it from a heterotetramer (Pol δ4) to a heterotrimer (Pol δ3), in response to DNA damage and also during the cell cycle. The biochemical mechanisms that lead to degradation of p12 are reviewed, as well as the properties of Pol δ4 and Pol δ3 that provide insights into their functions in DNA replication and repair. The second focus of the review involves the functions of two Pol δ binding proteins, PDIP46 and PDIP38, both of which are multi-functional proteins. PDIP46 is a novel activator of Pol δ4, and the impact of this function is discussed in relation to its potential roles in DNA replication. Several new models for the roles of Pol δ3 and Pol δ4 in leading and lagging strand DNA synthesis that integrate a role for PDIP46 are presented. PDIP38 has multiple cellular localizations including the mitochondria, the splicesosomes and the nucleus.
    [Show full text]
  • Genome-Wide CRISPR Screens Reveal Genetic Mediators of Cereblon Modulator Toxicity in Primary Effusion Lymphoma
    bioRxiv preprint doi: https://doi.org/10.1101/619312; this version posted April 25, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Genome-wide CRISPR Screens Reveal Genetic Mediators of Cereblon Modulator Toxicity in Primary Effusion Lymphoma Ajinkya Patil1, Mark Manzano1, and Eva Gottwein1 1Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, 60611 USA. Short Title: Cereblon Modulator Resistance Screens in PEL Corresponding Author: Eva Gottwein Department of Microbiology-Immunology Northwestern University Feinberg School of Medicine 320 E Superior St., Tarry Bldg., Room 6-735 Chicago, Illinois 60611 USA e-mail address: [email protected] Phone: +1-312-503-3075 Fax: +1-312-503-5101 Word Count Text: 3986 Word Count Abstract: 250 Figure Count: 7 main figures, 8 supplementary figures Table Count: 0 main manuscript, 8 supplementary tables Reference Count: 43 Scientific Category: Lymphoid Neoplasia 1 bioRxiv preprint doi: https://doi.org/10.1101/619312; this version posted April 25, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Genome-wide CRISPR/Cas9 screens represent a powerful approach to study mechanisms of drug action and resistance. Cereblon modulating agents (CMs) have recently emerged as candidates for therapeutic intervention in primary effusion lymphoma (PEL), a highly aggressive cancer caused by Kaposi’s sarcoma-associated herpesvirus. CMs bind to cereblon (CRBN), the substrate receptor of the cullin-RING type E3 ubiquitin ligase CRL4CRBN, and thereby trigger the acquisition and proteasomal degradation of neosubstrates.
    [Show full text]